Peter G. Klimko
49Patents
9h-index
28Co-inventors
71Inventor score
Filing activity: Jun 7, 1995 → Feb 13, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5889052A | Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension | Chemistry; Metallurgy | 102 | Expired |
| US6025392A | substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives | Chemistry; Metallurgy | 66 | Expired |
| US5994397A | Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives | Chemistry; Metallurgy | 52 | Expired |
| US7625927B2 | Method of treating glaucoma | Human Necessities | 51 | Active |
| US6184250A | Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension | Chemistry; Metallurgy | 49 | Expired |
| US6740674B2 | Use of proteasome inhibitors to treat dry eye disorders | Human Necessities | 28 | Expired |
| US5665773A | Cloprostenol and fluprostenol analogues and their use to treat glaucoma and ocular hypertension | Chemistry; Metallurgy | 26 | Expired |
| US6300328A | Selective inhibitors of adenosine monophosphate deaminase for the treatment of optic nerve and retinal damage | Human Necessities | 26 | Expired |
| US6645978B1 | Lipoxin A4 and its analogs for the treatment of dry eye | Human Necessities | 14 | Expired |
| US6576663B2 | 6-Keto prostaglandin F1&agr; and analogs for treating dry eye | Chemistry; Metallurgy | 8 | Expired |
| US5807892A | Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension | Chemistry; Metallurgy | 8 | Expired |
| US6417228B1 | 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension | Chemistry; Metallurgy | 8 | Expired |
| US6680339B2 | 15-fluoro prostaglandins as ocular hypotensives | Human Necessities | 7 | Expired |
| US6353000B1 | 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension | Chemistry; Metallurgy | 6 | Expired |
| US7807363B2 | Superoxide dismutase-2 expression for glaucoma diagnosis | Physics | 5 | Active |
| US7745461B1 | Method of treating dry eye disorders | Human Necessities | 4 | Active |
| US6353012B1 | 15-Hydroxyeicosatetraenoic acid-related compounds and methods of use | Chemistry; Metallurgy | 4 | Expired |
| US6331566A | Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use | Chemistry; Metallurgy | 3 | Expired |
| US6211226A | 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension | Human Necessities | 3 | Expired |
| US6331644A | 3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use | Chemistry; Metallurgy | 3 | Expired |
| US6552084B2 | Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders | Chemistry; Metallurgy | 3 | Expired |
| US6458854B2 | Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use | Chemistry; Metallurgy | 2 | Expired |
| US6353032B1 | Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use | Chemistry; Metallurgy | 2 | Expired |
| US6342525B1 | Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders | Chemistry; Metallurgy | 2 | Expired |
| US6462080B1 | Prostaglandin E receptor agonists for treatment of dry eye | Human Necessities | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.